Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GMDA - Greenlighting Gamida Cell

GMDA - Greenlighting Gamida Cell

Gamida Cell Ltd.
  • Gamida Cell recently executed a secondary at $4.50 a share on the back of positive Phase 3 clinical data for its lead asset.
  • The cell therapy biotech now trades at half its 2018 post IPO price despite a likely approval and launch of omidubicel in 2021.
  • The stock seems undervalued on a "sum of the parts" evaluation basis.  A full investment analysis follows in the paragraphs below.

For further details see:

Greenlighting Gamida Cell
Stock Information
Company Name: Gamida Cell Ltd.
Stock Symbol: GMDA
Market: NASDAQ
Menu
GMDA GMDA Quote GMDA Short GMDA News GMDA Articles GMDA Message Board
Get GMDA Alerts

News, Short Squeeze, Breakout and More Instantly...